MbrlCatalogueTitleDetail

Do you wish to reserve the book?
An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children
An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children
An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children
An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children
Journal Article

An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children

2011
Request Book From Autostore and Choose the Collection Method
Overview
Tetravalent meningococcal serogroups ACWY conjugate vaccines will provide an advantage to those at most risk of invasive meningococcal disease; namely young children. Co-administration of ACWY-TT with DTaP-HBV-IPV/Hib was assessed in a randomized trial in 793 children aged 12–23 months. Pre-specified criteria for non-inferiority of immunogenicity following co-administration versus separate ACWY-TT and DTaP-HBV-IPV/Hib administration were reached. One month post-vaccination, ≥97.3% of ACWY-TT vaccinees had rSBA titres ≥1:8 (all serogroups). Seroprotection/seropositivity rates against DTaP-HBV-IPV/Hib antigens were ≥98.2%. The safety profile of co-administration was similar to that of DTaP-HBV-IPV/Hib alone. ACWY-TT and DTaP-HBV-IPV/Hib co-administration during the second year would facilitate introduction of ACWY-TT into routine toddler vaccination schedules.
Publisher
Elsevier Ltd,Elsevier
Subject

Allergy and Immunology

/ Antibodies, Bacterial - blood

/ Antibodies, Viral - blood

/ antigens

/ Applied microbiology

/ Bactericidal activity

/ Bacteriology

/ Biological and medical sciences

/ children

/ Conjugate vaccine

/ Diphtheria-Tetanus-acellular Pertussis Vaccines - administration & dosage

/ Diphtheria-Tetanus-acellular Pertussis Vaccines - adverse effects

/ Diphtheria-Tetanus-acellular Pertussis Vaccines - immunology

/ DTaP-HBV-IPV/Hib combination vaccine

/ Female

/ Fundamental and applied biological sciences. Psychology

/ Haemophilus Vaccines - administration & dosage

/ Haemophilus Vaccines - adverse effects

/ Haemophilus Vaccines - immunology

/ Hexavalent vaccine

/ Humans

/ immune response

/ Infant

/ Male

/ Meningococcal Vaccines - administration & dosage

/ Meningococcal Vaccines - adverse effects

/ Meningococcal Vaccines - immunology

/ Microbiology

/ Miscellaneous

/ Neisseria meningitidis

/ Poliovirus Vaccine, Inactivated - administration & dosage

/ Poliovirus Vaccine, Inactivated - adverse effects

/ Poliovirus Vaccine, Inactivated - immunology

/ risk

/ seroprevalence

/ serotypes

/ Tetanus Toxoid - administration & dosage

/ Tetanus Toxoid - adverse effects

/ Tetanus Toxoid - immunology

/ Tetravalent meningococcal vaccine

/ vaccination

/ vaccines

/ Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)

/ Vaccines, Combined - administration & dosage

/ Vaccines, Combined - adverse effects

/ Vaccines, Combined - immunology

/ Vaccines, Conjugate - administration & dosage

/ Vaccines, Conjugate - adverse effects

/ Vaccines, Conjugate - immunology

/ Virology